MAPT and schizophrenia: However, unlike Aβ and tau protein aggregates in Alzheimer’s disease, α-synuclein protein aggregates in Parkinson’s disease and polyglutamine protein aggregates in Huntington’s disease [52–54], the role of protein aggregation in the pathogenesis of schizophrenia remains unclear.